BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2019
View Archived Issues
Clinical testing approved for the third-generation EGFR inhibitor XZP-5809
Read More
Gene minimizes mitotic chromosomal aberrations
Read More
FDA clears IND for phase I trial of BTX-A51 for AML and MDS
Read More
Results from a phase IIa study of reldesemtiv in patients with COPD
Read More
First-in-human results presented for adjuvant DC vaccine in patients with high-risk prostate cancer
Read More
Preliminary results of precision medicine-directed umbrella study of CCT301-38 and CCT301-59
Read More
First patient enrolled in phase III FALCON trial of bardoxolone for the treatment of AKPKD
Read More
Promising phase II efficacy data presented for NRX-101
Read More
CD206 plays a prognostic role in patients with DM/ILD
Read More
TP-0903 advances into phase Ib expansion stage in patients with advanced solid tumors
Read More
Inflazome patents new NLRP3 inflammasome inhibitors
Read More
Takeda identifies hSTING agonists
Read More
CSIR synthesizes new TLR9 antagonists
Read More
Shanghai ECUST Biomedicine patents tubulin polymerization inhibitors
Read More
Beijing Jialin Pharmaceutical discovers SMARCA2-targeting drugs for cancer
Read More
Patient recruitment ongoing in phase I study of BOS-475
Read More
Nonclinical toxicology studies support long-term administration of oral ibrexafungerp
Read More
First-in-human data for M-2000 in patients with early-stage breast cancer
Read More
Shionogi & Co. patents new antibacterial compounds
Read More
GT Biopharma provides clinical update for two phase I/II studies of GTB-1550
Read More
IVI and MCRI to coordinate global push to develop vaccine against Strep A
Read More
First study to test osilodrostat in children and adolescents with Cushing's disease
Read More
First patient dosed in phase I study of ALN-AGT
Read More
